A ccording to the World Health Organization (WHO) and the US Department of Commerce, by 2050, the number of adults over the age of 60 will nearly double, both in the United States 1 and worldwide, leading to the possibility of older adults outnumbering young adults for the first time. 2 As the population ages, early identification of preclinical disabilitythe transitional state between impairment and disability occurring before individuals perceive difficulty in task performance 3 -becomes an essential aspect of promoting functional independence and quality of life in the older adult population. As independent mobility is lost, the prospects of remaining in the community fade, whereas the likelihood for disease and poorer quality of life increases. 4 Physical therapists have a unique role within the medical field to identify movement system impairments and prevent progression to disability.
Over the past 20 years, the physical therapy profession has increasingly advocated that physical therapists be recognized by patients as the practitioners of choice for treating movement system impairment. 5, 6 As such, annual mobility screens in middle-aged and older community-dwelling adults could be implemented into standard physical therapy practice. Annual mobility screens are sessions lasting half to 1 hour where clients are assessed to determine their current health status and future health risks. 7 Preventive health screening is commonly used in other clinical areas 8, 9 and would identify and address specific movement-based deficits and track patient health over time. 7 Individualized home exercise programs could then be developed with the intention of preventing disability, while also improving independence and quality of life. 4, 5, 10 Early identification of preclinical disability, as identified through physical performance measure (PPM) scores, during annual screening can address functional deficits before they lead to permanent modification of activities. PPMs should be used as markers of preclinical disability as they can better discriminate change in healthy and higher functioning individuals compared with self-report measures. 11 For PPMs to be used in an annual physical therapy screen, where many individuals might lack a clinical disability, studies need to begin using these PPMs to assess individuals who are healthy and free of disabilities. Although there is much literature on the ability of PPMs to predict functional decline in older adults, test batteries such as the Short Physical Performance Battery, Berg Balance Scale, and Dynamic Gait Index were excluded to focus on the clinical usefulness of single-item tests that could be administered quickly as screening tools. The purpose of this systematic review was to identify PPMs that can be easily administered during annual physical therapy screens to detect preclinical disability in middle-aged and older adults.
Methods Date Sources and Searches
An electronic search was conducted in accordance with PRISMA guidelines. 12 The following electronic databases were searched from the time of their creation to September 2017: CINHAL, PubMed, Scopus, and Web of Science. A combination of 4 concept-based search terms related to "predictive validity," "functional assessments," "mobility decline," and "community-dwelling" were selected (Fig. 1) . No limits or filters were applied to the search results. Selected databases were searched using comparable strategies. A hand search of reference lists and an additional webbased scoping search were conducted to ensure a comprehensive review.
Study Selection
Studies were individually selected and screened by 2 individuals. A stepwise process of inclusion/exclusion was followed, 12 first by titles, then by abstracts, excluding those articles not related to the objective of this review. Full-text review was conducted by 2 individuals to identify articles that met the inclusion criteria. Discussion occurred until agreement was reached in the event of a discrepancy (Fig. 2.) .
Peer-reviewed, prospective, longitudinal studies, available in English, were included if they met all the following inclusion criteria:
1. Middle-aged and older adult participants (defined as adults ≥45 years old), living in the community independently.
2. Participants who were healthy at baseline (no history of falls, significant cardiovascular, orthopedic, cognitive, or neurological impairments); individuals with identified chronic conditions at baseline were included only if statistically controlled for in the results.
3. Single-task PPMs that could be easily administered or replicated in outpatient clinical settings without specialized equipment or advanced training.
4. Data on individual tasks within a test battery (ie, data on gait speed within the Short Physical Performance Battery) included; studies that reported only total or summary scores were excluded.
5. Participants followed prospectively for at least 1 year.
Data Extraction
Data extraction was performed simultaneously by 2 individuals. Participant characteristics (number of participants, age, baseline health status, follow-up time frame), relevant PPMs (eg, grip strength, gait speed, Timed Up & Go), and disability outcomes (mobility disability, activities of daily living [ADL] disability, falls, hospitalization) were extracted (Tab. 1). When available, effect sizes were extracted from the included studies.
Extracted effect sizes included relative risk (RR), 13 odds ratio (OR), [14] [15] [16] hazard ratio (HR), 17 and rho correlation (r). 18 In cases where effect sizes were not explicitly reported, 19, 20 Data were extracted and calculated individually into article-specific representations of effect sizes (Tab. 2). When additional information was needed for data extraction, authors were contacted to try to obtain pertinent data.
Quality Assessment
The Quality Assessment Tool for Cohort Studies II (Q-Coh II) was used to assess the methodological risk of bias in eligible studies. This assessment tool is an updated version of the retrospective checklist, the Quality Assessment Tool for Cohort Studies, 22 which has been used previously to assess the methodological quality of cohort studies. 23 This tool includes 4 screening questions and 1 subjective inference question to determine compatibility with the Q-Coh II. The remaining 12 objective items assess bias across 5 domains: selection bias (2 items); exposure measures (2 items); performance bias (2 items); outcome measures (4 items); and attrition bias (2 items). Item questions are answered as "yes," "no," "not reported," "presumably," or "doubtfully," referring to whether or not the information was obtainable from the article.
Based on the answers to the items within each domain, a subjective inference question asks the reviewer to make a judgment on the effects of any noted bias. The total score is then calculated, with each "yes" response equaling 1 (a score of 12/12 being the highest possible, indicating low bias). Each study was assigned a rating of good, acceptable, or poor according to the number of domains that could have potentially introduced a source of bias (0-1 domain is considered good, 2 domains is acceptable, and > 2 is poor). 22 Studies were independently evaluated by 2 individuals. In cases of quality assessment discrepancies, agreement was obtained through discussion between the 2 raters.
Data Synthesis and Analysis
Due to the effect-size heterogeneity within the included articles, a meta-analysis was not completed. Rather, a synthesis of the best available evidence was conducted, examining the methodological quality of each article and the predictive validity (measured in effect size) of each PPM to identify preclinical disability across multiple constructs.
Effect sizes for the 8 included articles were grouped by type of PPM or predictor variable (balance, reaching, chair transfer, etc) and then compared across 4 constructs, which were created to guide the synthesis of information. These constructs were established by examining the type of disability outcome presented in each article and then grouping studies with similar topics. The 4 constructs and definitions include:
• Mobility: the inability to walk half a mile and walk up and down 1 flight of stairs independently, 24, 25 and decreased walking speed.
• ADL: the inability to perform 1 or more ADLs without help 16 or with difficulty. 15 • Falls: an "unexpected contact of any part of the body with the ground." 26 • Hospitalization: being admitted to an acute care hospital. Admissions to a skilled nursing facility were not included within this construct due to the definition used within included articles.
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Results
Initially, 4929 titles were identified through the database and hand search. After 176 duplicate articles were removed, 4753 articles were screened by title and abstract, with 64 determined to be eligible for full text assessment. Eight longitudinal cohort studies met the inclusion criteria (Fig. 2) . [13] [14] [15] [16] [17] [18] [19] [20] These 8 studies used various PPMs (the predictor variables) to establish baseline markers of preclinical disability. Participants were tracked across time to determine if their baseline physical performance scores were correlated with future disability outcomes within the 4 constructs for the purpose of determining whether the PPMs were valid in predicting future disability.
Gait Speed
Five studies 13, [15] [16] [17] 20 examined gait speed PPMs as the marker of preclinical disability. Gait speed was a statistically significant identifier of preclinical disability within the mobility, ADL, and falls constructs.
Three of the 5 studies 16, 17, 20 examined disability outcomes within the mobility construct. Cesari et al 17 examined 2 levels of mobility disability: persistent lower extremity (LE) limitation and persistent severe LE limitation. Persistent LE limitation was defined as "two consecutive semiannual reports of having any difficulty walking one-quarter of a mile or climbing up 10 steps without resting," 17 whereas persistent severe LE limitation was defined as "having a lot of difficulty or not being able" 17 to perform the above tasks. Participants were contacted by telephone every 6 months and made clinic visits annually until contact was lost or death occurred (median follow-up time 6.9 years). When participants' usual gait speed over a 6-m course was less than the cutoff of 1 m/s, participants were Wang et al 20 used 3 variations of gait speed measures as predictor variables to help delineate which participants could be at risk for mobility disability, defined in this case as the inability to walk half a mile and walk up and down stairs independently, over a 2-year follow-up period. Only fastest gait speed (OR = 7.92), measured as the time for participants to walk a 15.24-m course using their fastest walking pace, was statistically significant.
Ostir et al examined time to walk 8 feet as the predictor of future mobility-related disability at the 2-year follow-up. Mobility-related disability was defined as the "inability to walk a half mile or climb stairs without help." 16 Participants who took 9 s or longer were 3.4 times (95% CI: 1.8-6.5) more likely to have mobility-related disability; those between 6 and 8 s were 2.6 times (95% CI: 1.4-4.9) more likely; and those between 4 and 5 s were 2.1 times (95% CI: 1.2-4.0) more likely.
Within the ADL disability outcome Ostir et al 16 also found that when participants' 8-feet walk times were 9 s or greater, participants were 5.4 times (95% CI: 1.2-23.6) more likely to experience ADL disability at 2-year follow up. When participants' times were less than 9 s, gait speed was not a significant predictor of ADL disability. Huang et al 15 examined the relationship between baseline gait speed over a 4-m course and the onset of ADL difficulty at 6, 12, and 18-month follow-up. The data for the 6-month follow-up were not included in the data analysis due to the established inclusion criteria. This study determined that gait speed was not a statistically significant predictor of ADL difficulty at 12 (OR = 0.568, 95% CI: 0.02-16.00) or 18 (OR = 0.286, 95% CI: 0.01-8.79) months.
One study 13 found statistical significance between baseline gait speed, using the 6-meter walk time, and (n = 4, 9) e r ic e e c e i re n n n n (n = ) 
Balance
Two studies 16, 17 examined balance PPMs as the marker of preclinical disability. Balance PPMs identified preclinical disability within the mobility, ADL, Gait speed for 4 m 15 12 
Chair Transfers
Four studies 13, 16, 17, 20 examined chair-transfer PPMs as the marker of preclinical disability. Chair-transfer PPMs identified preclinical disability within the mobility, ADL, and falls constructs. The disability outcome of 1 study 17 did fall within the hospitalization construct but these results were not statistically significant.
Three studies 16, 17, 20 used baseline chair-transfer PPMs scores as the predictor variable of future mobility disability. Cesari et al 17 found that when participants took longer than 17 s to complete a five times sit-to-stand (FTSS) test they were 1.59 times (95% CI: 1.41-1.78) more likely to report persistent LE limitations and 1.62 times (95% CI: 1.37-1.91) more likely to report persistent severe LE limitations. Ostir et al 16 found incident mobility disability was 2.7 times (95% CI: 1.7-4.2) more likely to occur with individuals who took 16.5 s or longer to complete the FTSS, and 2.2 times (95% CI: 1.4-3.5) more likely with those who took between 13.6 and 16.4 s. There were no significant findings within the groups that completed the task in less than 13.5 s. Wang et al 20 found the FTSS to be statistically significant (OR = 1.39) for increased risk of mobility disability at 2-year follow-up.
Within the ADL 16 and falls 13 constructs, only the chair-transfer PPM was significant for each disability outcome. Ostir et al 16 found when participants' FTSS scores were ≥ 16.5 s (OR = 2.8, 95% CI: 1.2-6.4) this test was considered a significant predictor of ADL disability. In the falls construct, Tiedemann et al 13 found that individuals who took ≥ 12 s to perform the FTSS had 2.0 times (95% CI: 1.3-3.0) greater fall risk compared with those below the 12-s threshold.
Strength and Power
Four studies 14, 15, 19, 20 examined strength and power PPMs, which only identified preclinical disability within the mobility construct. One study 15 reported on baseline grip strength and future ADL difficulty but these results were not statistically significant.
Rantanen et al 14 examined midlife handgrip strength as the predictor of disability over 25 years. Participants' midlife hand-grip strength was divided into 3 tertiles: low, middle, and high. The low and middle tertiles were then compared with the highest tertile regarding measures of decline. For data extraction, only the comparison between low and high tertiles was examined to compare extremes. When adjusted by anthropomorphic, demographic characteristics, and chronic conditions, the interpretation of data from Rantanen et al indicated participants with low grip strength were 2.77 times (95% CI:1.70-4.54) more likely to have a walking speed of less than 0.4 m/s and 2.73 times (95% CI:1.19-6.27) more likely to be unable to rise from a chair, when compared with those with high grip strength.
Hicks et al 19 used maximal isometric knee extension strength, unilateral seated ankle plantarflexion leg power, and grip strength as the PPMs to predict incident mobility disability (an inability to walk 1 km or climb stairs) over a 3-year follow-up. Individual results were obtained and reported based on sex. All reported effect sizes were trivial, indicating little association between baseline scores and future mobility disability. The results from the grip strength PPM testing within the Wang et al study 20 also lacked statistical significance.
Reaching
Two studies 18, 20 examined reaching PPMs as a marker of preclinical disability. However, reaching PPMs did not successfully identify preclinical disability in any of the 4 established constructs. Wang et al 20 determined that standing forward reach (in centimeters) was not a statistically significant predictor of future mobility disability. Boulgarides et al 18 recorded fall(s) in community-dwelling older adults by collecting follow-up data via telephone or email every 2 to 4 weeks throughout the year following baseline testing. Data extracted for the functional reach test (as well as the Timed Up & Go data reported below) were reported on a continuous spectrum and not as cutoff scores. The correlation between the functional reach test and fall risk was not significant (r = 0.013).
Multidimensional Measures
Three studies 13, 18, 20 examined multidimensional PPMs as the marker of preclinical disability. However, these PPMs only successfully identified preclinical disability within the falls construct. Two studies 18, 20 reported on the Timed Up & Go as a marker of preclinical disability within the mobility and falls constructs respectively, but the reported effect sizes for both studies were statistically insignificant.
Of the 5 individual PPMs presented in the Tiedemann et al study 13 that were considered multidimensional PPMs, only the predictor variables of the alternate step test and stair descent test could identify preclinical disability within the falls construct. This study found that those individuals who completed the alternate step test in ≥ 10 s had a 2.3 times (95% CI: 1.4-3.5) greater fall risk than those who completed the test in less than 10 s. Individuals who took ≥ 5 s to descend 8 stairs had a 1.7 times (95% CI: 1.2-2.6) greater fall risk than individuals completing the task in less than 5 s.
Risk of Bias Within Studies
All included studies scored ≥ 10/12 and had no more than one domain that could have been a source of bias, indicating good methodological quality (Tab. 3). Although overall methodological quality was considered good, 3 studies 13, 14, 19 did not definitively state if the exposure variables (type of decline) of interest were properly measured. Rantanen et al 14 did not report if the length of follow-up was the same for all participants. In 2 studies, 13, 18 it was established by consensus of 2 quality-scale interpreters that the length of follow-up was insufficient to detect the effect of exposure variables on the outcomes. Three studies 13, 19, 20 did not report if the percentage of participants who dropped out was acceptable, with 2 additional studies 14, 17 failing to state the percentage of participants who dropped out altogether. Two studies 15, 16 had dropout rates that were large enough to introduce a source of bias. Lastly, 7 included studies 13, 14, [16] [17] [18] [19] [20] omitted comparative descriptive data on the completers versus dropout participants, although in 6 of the 7 studies 13, 14, [17] [18] [19] [20] the attrition rates were low and were assessed as not impacting the overall results. Only 1 study 15 reported that those who dropped out were not statistically different from those who remained in the study.
Discussion
The aim of this systematic review was to identify PPMs that can be used to identify preclinical disability in middle-aged and older adults in the outpatient-based clinical setting. Findings from this review indicate that gait speed, standing balance tests, and multiple sit-tostands can be used to identify preclinical disability for the disability-related outcomes of mobility disability, ADL disability, fall(s), and hospitalization. These PPMs are valuable resources when evaluating middle-aged and older patients for risk of future disability and can be safely, and conveniently, administered by physical therapists in clinical practice to predict disability (Fig. 3) .
Clinicians can easily apply information from this study due to the ease of administration of the included PPMs, which can quickly be implemented in a clinical screen, such as the annual physical therapy checkup. The objective nature of PPMs permits a definitive clinical picture over time based on data gathered during annual physical therapy screens. The measures examined in this review can be easily administered in the clinic and applied to multiple disability outcome variables. Other systematic reviews on this topic have either analyzed a single construct [27] [28] [29] (ie, falls or ADL disability) or included measurements that were purely subjective, failing to provide direct measurements of physical performance. 30, 31 The potential advantages of PPMs over self-report measures include less influence from language and education, reproducibility, 32 and ability to detect differences in individuals who are higher level performers. 11 These 2 types of measures have been shown to assess different characteristics of function in older adults, 33 therefore performance measures do not replace self-report measures but rather supplement disability reports. 34 The results investigated in this review complement those identified in similar reviews 27, 28 regarding the use of gait speed, multiple sit-tostands from a chair, and grip strength for predicting negative events resulting from functional mobility decline. This review establishes the link between lower baseline performances on PPMs across multiple areas of disability as a person ages. With this information, physical therapists can identify impairments indicative of future disability and address deficits before permanent alteration of the movement system.
In an attempt to capture a broad picture of disability across multiple constructs, the constructs themselves became a limiting factor due to the variation of assessment tools used within each category. For example, the limited number of measures included in the hospitalization construct restricted the use of a few measures that accurately predict disability across all 4 constructs. Some studies referenced similar measures of preclinical disability but used different procedures for testing. The studies that used standing balance measures included different variations of balance tests. Furthermore, the heterogeneity in the reporting of risk prediction statistics made it difficult to directly compare results across studies, PPMs, and constructs. Inclusion of only studies with participants who were healthy at baseline might limit the external validity of this systematic review. However, in cohort studies it is necessary to enroll participants before the outcome of interest (disability) is present. Additionally, studies were excluded based on the presence of confounding diseases (or the lack of statistical correction for these conditions) due to their potential relationship to functional limitations. 35 Heterogeneity among follow-up lengths limited direct comparison between studies as different follow-up timeframes (eg, 1 year vs 25 years) 13, 15, 16, 18, 20 could change the likelihood of the outcome of interest (disability) occurring.
Figure 3.
Physical performance measures to identify preclinical disability. ADL = activities of daily living; PT = physical therapy.
In particular, the Rantanen et al study, 14 with an outlier follow-up time of 25 years, could have limited clinical use due to the lack of reporting on shorter disability-onset time frames.
Another limitation is the inconsistent use of cutoff scores for the baseline measures across selected studies. Lastly, the original computer-based search failed to identify multiple articles that fit the inclusion criteria of this systematic review. A hand search was conducted that aimed to identify articles that were not originally identified.
Based on the results of these studies, it would be appropriate to suggest that physical therapists annually assess patients after the age of 45 for functional mobility status using the 3 PPMs of gait speed, standing balance, and multiple sit-to-stands. These measures were found to be good markers of preclinical disability for middle-aged and older adults. Identifying preclinical disability in this population will allow early intervention 3 and potentially decrease disability over a lifetime. In early preclinical disability, the patient can be unaware of any difficulty with activities but continue to be at increased risk for disability. 36 Therefore, healthy participants were chosen at baseline to specifically focus on decline over time to demonstrate the progression of preclinical disability into disability. According to the Academy of Geriatric Physical Therapy, older adults should obtain yearly screens for fall risk as well as concerns with balance or walking abilities. 37 Individuals identified as "at risk" should have a multifactorial assessment and be treated with targeted interventions to avoid or prevent functional decline. 37 It is important for clinicians to note that when an individual falls into an "at risk" score range, it is not inevitable that he or she will develop disability in future. Physical therapists must educate their clients on the potential benefits of physical therapy interventions while creating realistic expectations of the role of preventive interventions. The findings from this review lend evidence for the use of the gait speed assessments, single-leg stance balance test, and the FTSS in the current version of the American Physical Therapy Association's Annual Checkup Form Template. 38 The authors recommend future research to further examine the predictive validity of PPMs for disability. Future studies should also account for differences in the individuals of the sample population who are excluded or have removed themselves from the study. It would best serve future clinicians to have access to research including a longterm epidemiological study following healthy adults from midlife until death specifically using gait speed, standing balance, and chair sit-to-stands. This could be achieved by including PPMs that have displayed adequate predictive validity (gait speed, standing balance tests, multiple sit-to-stands) to track various measures of disability over time using the annual checkup by a physical therapist. Data collected over time from PPMs used in annual screens would provide an improved measure of the PPMs' predictive validity in relation to future disability. Extending the time frame over which data are collected on PPMs could establish a more predictable time line for development of disability based on baseline markers of preclinical disability. With further research of this nature, use of these PPMs could be considered best practice in assessing for markers of preclinical disability over time.
